Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › GPC3 and ASGPR1 double-targeted transgenic immune effector cell and use thereof

GPC3 and ASGPR1 double-targeted transgenic immune effector cell and use thereof

US Patent 11453860 · Granted Sep 27, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and apparatuses for determining a placement and duration of a transient 2025
Method and composition for treating tumors2025
Antibody against glypican-3 and application thereof2024
Antibody against glypican-3 and application thereof2024
Dynamic MCS offset for short TTI2024
Methods providing RACH occasion indication for random access procedure initiated2024
Polycarboxylic acid water-reducing agent with high adaptability to temperature a2024
Immunologic effector cell of targeted CLD18A2, and preparation method and use th2024
Immunologic effector cell of targeted CLD18A2, and preparation method and use th2024
Immunologic effector cell of targeted CLD18A2, and preparation method and use th2024
Amphipathic multifunctional hybrid nanoparticle, and preparation method therefor2024
Compositions and methods of cellular immunotherapy2023